Letter to the Editor: Safety of proton pump inhibitors during pregnancy

ENTIS colleagues from the Teratology Information, Training and Research Center, Terafar at Izmir Katip Celebi University in Turkey have written a letter to the editor of the Alimentary Pharmacology and Therapeutics journal highlighting some key limitations in a systematic review and meta-analysis of proton pump inhibitor use in pregnancy which was published in January 2020. The authors response to the letter has also been published.

Photo by Scott Graham on Unsplash